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Background: Patient-centered perspectives on self-monitoring of blood glucose (SBMG) were assessed in adults with
type 2 diabetes using a self-regulation conceptual framework.
Methods: Participants (N = 589; 53 % female) were adults with type 2 diabetes who were recruited during routine
appointments at a diabetes outpatient clinic in the Southeastern/lower Midwestern region of the United States.
Results: Participant’s had varying perceptions regarding provider recommendations for SMBG (responder n= 380).
Personal blood glucose testing patterns were also varied and reports frequently omitted (responder n= 296). Respondent’s
most frequent personal pattern was to test “occasionally, as needed,” which did not differ by insulin use status, gender or
age. In those not prescribed insulin, HbA1c reflected better control in those testing at least once per week (p = .040) or
with a blood glucose goal (p = .018). 30.9 % endorsed at least monthly perceived encounters with SMBG barriers, with
higher reports by women (p = .005) and younger (p = .006) participants. Poorer glycemic control was observed for
participants with more frequently reported scheduling (p= .025, .041) and discouragement (p = .003) barriers.
Conclusions: Findings suggest that many may experience difficulty integrating SMBG into their lives and are unsure of
recommendations and appropriate function. Research is needed to promote best practice recommendations for SMBG.
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Diabetes Mellitus (diabetes) is a rapidly increasing public
health crisis, impacting over 300 million people globally
[1]. When glucose is poorly controlled, risks of comorbi-
dies, health complications and mortality are increased.
In the face of the global epidemic, an understanding of
approaches to stemming the tide of diabetes-related mor-
bidity and mortality is critical [1]. Several large, prospective
trials have revealed that many micro and macrovascular
complications can be avoided or prevented with strict
management of blood glucose control [2]. Studies suggest
that much of the effective management of diabetes comes
through intensive lifestyle change and regular monitoring* Correspondence: barbara.stetson@louisville.edu
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creativecommons.org/publicdomain/zero/1.0/of health behaviors and physical markers, such as weight
and blood glucose levels, in the context of competing life
priorities [3]. While research highlights the clear benefits
of lifestyle change and the feasibility of achieving adher-
ence to the demanding diabetes regimen, previous studies
have been based on carefully selected participants. Transla-
tion of the behavioral management approaches used in
clinical trials to real-world clinical settings has proved chal-
lenging to date [4] and is an important direction for
research as interventions to assist individuals with diabetes
in becoming engaged in the self-management of their dia-
betes can greatly help reduce risk of complications [5].
Self-monitoring of blood glucose levels (SMBG) is a key
self-management component of the U.S. National Standards
for Diabetes Self-Management and Education Practice
Guidelines, which emphasize the critical role of behavioral
goal-setting and decision-making [5, 6]. In recent years,icle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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of the use of SMBG in the type 2 diabetes or non-insulin
prescribed population [7]. Current standards of diabetes
care and education emphasize the critical perspective of
the person who is living with diabetes and advocate a
patient-centered approach to care [2, 8]. While the result-
ant increase in research has called much-needed attention
to the patient experience of SMBG and to SMBG
behaviors, much of this research has not considered
patient-centered perspectives or drawn on the decades
of behavioral science literature on goal-setting, self-
regulation, social ecological frameworks and problem
solving [9]. Behavioral and psychosocial issues are much less
likely to be addressed relative to routine clinical care and
prevention and management of physical complications [10]
and behavioral research in real world clinical settings lags
behind recommendations. This discrepancy highlights the
critical need for assessment of patient perspectives and
SMBG related outcomes, using a patient-centered approach.
In order to address the limited consideration of patient
perspectives on SMBG in clinical settings and studies,
we propose that SMBG perceptions and behaviors be
considered from a patient-centered perspective and a
self-regulatory framework [11, 12]. Many factors related
to patient characteristics and perspectives can be seen as
contributing to the process of self-regulation such as
knowledge, cultural background and beliefs, goal setting,
emotional coping skill, and competing life priorities [13].
Recent studies have found that adults with type 2 dia-
betes who displayed stronger cognitive abilities, such as
planning and problem solving, were more likely to en-
gage in recommended self-management strategies than
those with less well-developed skills [14] and that prob-
lem solving skills predicted better control of hyper and
hypoglycemic episodes [15].
In addition to the need for theoretically based data on the
perceptions and use of SMBG, data are needed to under-
stand the actual SBMG practices of real-world clinical pa-
tients beyond the highly select participants in clinical trials.
Surprisingly, little is known about patient perspectives on
monitoring and their SMBG practices in clinic settings.
Also, the limited translation of behavioral diabetes trials has
constrained the integration of behavioral and social eco-
logical assessments into clinical practice. By drawing from
patient-centered research, behavioral and translational sci-
ence may in turn, make a significant contribution to inter-
ventions that address the personal practices, barriers and
patient outcomes most related to adherence to SMBG and
move behavioral diabetes research toward interventions
and practices that can increase self-management success.
Study aims
The present study aims to increase understanding of
patient perspectives on self-monitoring of blood glucoserecommendations and their personal SMBG practices and
experience of SMBG barriers within a self-regulation
framework. Specifically, patient perceptions of provider
recommendations and patient-reported SMBG behavioral
practices and barriers are investigated in a diabetes clinic;
associations between these factors and individual and illness
characteristics are also examined.
Method
Design
The study used a cross-sectional design. Information per-
taining to self-care behavior and health perceptions was
obtained from a validated, self-report questionnaire. Type
2 diabetes status and insulin use/non-use and physical
parameter data were obtained from medical chart review
by trained clinic staff.
Recruitment
The study was conducted at a hospital-based outpatient
diabetes clinic in Southern Indiana in the Southeastern/
lower Midwestern region of the United States. The clinic
offers a variety of treatment, education, nutrition and ex-
ercise programs for patients with diabetes or endocrine
disorders and their families.
Participants (N = 589, 53 % female) were recruited by
clinic staff during routine outpatient clinic appointments
at the time of check-in. Inclusion criteria were type 2
diabetes, 21 years though 90 years of age and able to read
and write English. Exclusion criteria were type 1 diabetes,
pregnancy, and cognitive impairment or severe mental ill-
ness precluding questionnaire completion. The study was
approved by the University of Louisville Institutional Re-
view Board. Informed consent was collected from all
participants.
Measures
The following were obtained from clinical medical chart
data corresponding to the recruitment appointment: Height,
weight and Hemoglobin A1c (HbA1c). HbA1c is an index
of blood glucose control over the previous weeks to
months; higher levels are a marker for poorly controlled
diabetes and are associated with increased morbidity [16].
The Personal Diabetes Questionnaire (PDQ), a brief,
clinically-focused, structured self-report measure of patient
centered diabetes-related self-management behaviors, per-
ceptions, and barriers [17] was completed by participants
while waiting for clinic appointments or at home and
returned by mail using pre-stamped envelopes. The PDQ
scoring scheme is based on the behavioral domains of dia-
betes care, with subscales representing each self-care behav-
ior. Select items and subscales were used to assess a
number of self-regulatory factors including frequency of en-
gaging in SMBG, knowledge (perceptions of provider rec-
ommendations), goal setting, barriers to SMBG (e.g. being
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tions of glucose control.
Statistical approach
All analyses were conducted using SPSS version 20.0
[18]. Participants were grouped dichotomously to reflect
responses on items related to SMBG barriers and fre-
quency (based on modal SMBG responses), insulin use
status (whether or not they are prescribed injectable,
subcutaneous insulin), gender and age group in order to
statistically examine these variables as they relate to one
another. Age was divided at 60 years due to sample dis-
tribution and research precedent [19]. For continuous
variables (such as BMI and HbA1c), Two and Three-way
ANOVA, T-test, and Chi-square were used. For ordinal
and nominal data, Spearman’s Rho and Kruskal Wallis
H-test analyses with Mann–Whitney U post hoc testing
using the Holm corrections [20] were used. Holm cor-
rections are appropriate for multiple comparisons of in-
dividual ordinal items that use Mann–Whitney U post
hoc tests. The correction consists of a reduced p-value
required for significance (p = 0.05/number of compari-
sons) with each required p-value increasing sequentially.
For example, for an item with 6 ordinal response op-
tions, the results are first organized in order of signifi-
cance. The finding with the lowest associated p-value is
then compared with a required p-value for statistical sig-
nificance of 0.05 divided by the total number of compar-
isons, or 6 (=0.00833). The second lowest p-value is
then compared with 0.05 divided by the remaining num-
ber of comparisons, or 5 (=0.01). This process continues
until the final finding (the sixth in this case) is compared
with the uncorrected p-value (0.05).
Results
Sample characteristics
The sample included adults with type 2 diabetes, pre-
dominantly White American (96.1 %), with a mean age
of 55.4 (SD = 13.04) years and 83.3 % with a high school
degree. Having a subcutaneous insulin prescription (on
insulin) was common (34.1 %)—even more so in those
over 60 years of age [X2(2, 553) =7.324, p = .005] and fe-
male [X2(6, 553) =64.99, p < .001]. HbA1c (%) reflected
moderate control [M = 8.614 (1.95)], consistent with a
typical outpatient clinic sample (e.g. [21]) and was gener-
ally poorer [F(3, 584) =11.980, p = 0.001] in younger
males [M = 8.65 (1.93)].
Patient perceptions
Perceptions of provider recommendations
Participants were asked to respond to questions about
provider recommendations and their actual typical fre-
quency of engaging in SMBG; several participants left one
or both of these items blank. Regarding perceptions ofprovider recommendations, 35.5 % of the sample left the
item blank. Of those who did respond (N = 380), n = 14
(4 %) indicated that they (had) “not been told to test;” all
but three of these individuals were not on insulin.
Perceptions of control
Control perceptions were generally supported by medical
outcomes, with participants who rated their blood glucose
control as ‘good’ to ‘excellent’ (26.3 %) tending to have
lower HbA1c levels than those who indicated that they
have ‘a few problems,’ ‘poor control,’ ‘very poor control,’ or
did not know [F(1, 483) = 83.74, p < .001]. Many, in both
insulin groups, reported having high blood sugar ‘nearly
daily’ (37 % on insulin, 35.2 % other). Reports of low blood
sugar were more common in those on insulin (33.2 % at
least once per week) than those not on insulin [15.8 %;
F(1, 430) =131.77, p < .001].
Reported self-monitoring behaviors
A very large number of participants left an item reflecting
SMBG frequency blank (50.3 %). Those not responding
were excluded from subsequent SMBG behavior analyses
but were examined for group features (i.e. differences in
gender, age and insulin prescription status). The only sig-
nificant difference was that the non-responders were more
likely to be on insulin [X2(1, 552) =44.563, p < .001].
In those who responded (n = 296), SMBG frequency was
reported as occurring at least one to two times weekly for
46.8 % (n = 203); the modal response was “occasionally, as
needed.” Group differences were found when collapsing
responses into dichotomous groups to compare those en-
gaging in SMBG at least once per week and those engaging
in SMBG less than once per week. Individuals prescribed
insulin were more likely to report that they tested less than
once per week (17.0 %) compared with those not using in-
sulin [31.0 %; F(1, 552) =36.833, p < .001].
Perceptions of barriers to self-monitoring
The majority of the sample (69.1 %) did not endorse bar-
riers to SMBG that occurred more than once monthly.
In those participants who reported that they engage in
SMBG at least once per week (n = 136), higher overall
SMBG barrier scores (reflecting perceptions of more fre-
quent barriers) did not differ by insulin prescription but
were associated with female gender [F(1, 136) = 8.292,
p = .005] and younger age [F(1, 136) = 7.685, p = .006].
The endorsement of specific barriers was fairly con-
sistent across age, gender and insulin groupings with
barriers related to scheduling, such as being away from
home or experiencing changed plans, as the most fre-
quently and universally encountered. Higher scores on a
schedule-related barrier subscale (α = .80), did not differ
based on insulin prescription status or having a target range
but were associated with younger age [F(1, 130) =10.712,
Ward et al. Journal of Diabetes & Metabolic Disorders  (2015) 14:43 Page 4 of 7p = .001] and female gender [F(1, 130) =5.502, p = .021],
which is consistent with higher overall SMBG barriers
reported in the young and female in this sample.
SMBG barriers and associations with testing frequency
Exploratory analyses examined whether perceptions of bar-
riers differed by reported testing frequency and insulin use
status. Based on observed differences in testing patterns,
participants were divided into four groups: 1) those on in-
sulin who reported that they engage in SMBG at least once
per week (n = 29), 2) those on insulin engaging in SMBG
less than once per week (n = 28), 3) those not on insulin
engaging in SMBG at least once per week (n = 105) and 4)
those not on insulin engaging in SMBG less than once per
week (n = 90). No significant group differences were found
in the reported degree of scheduling barriers to SMBG.
More broadly, a subscale related to overall SMBG barriers
differed by those on insulin only, t(254) =3.28, p = 0.002,
with those engaging in SMBG less than once per week hav-
ing significantly higher barrier scores [M = 2.40 (1.10)]
indicating the perception of more frequent barriers to
SMBG than those engaging in SMBG more frequently
[M = 1.62 (0.63)]. This statistical difference remained sig-
nificant after using a Holm correction for multiple compar-
isons. See Table 1 for a chart summarizing significant
findings with Kruskal Wallis H-tests of ordinal data; Holm-
corrected p-values are provided in the far right column.
Behaviors and perceptions associated with physiological
outcomes
Reported frequency of SMBG was associated with better
glycemic control in those not on insulin only, with those
reporting that they engage in SMBG 1-2 times per week or
more displaying lower HbA1c levels [M = 7.65(0.18)] rela-
tive to the other groups [M = 8.20(0.20); F(1, 226) = 4.287,Table 1 Significant Statistical findings for comparisons of Hemoglob
Barrier to SMBG Kruskal-Wallis
test X2




Away from Home 12.832 0.025 4-6x/week 12 9.15
1x/month or less 63 7.90
Never 278 7.90
2-3x/month 80 7.95
1+ x/day 12 7.00
Discouraged 17.764 0.003 Never 355 7.70
1-3x/week 18 9.30
2-3x/month 43 8.40
Busy scheduleϯ ϯ 11.554 0.041 Never 106 8.10
4-6x/week 15 9.30
1-3x/week 17 9.10
Note: *indicates significance after compared with Holm corrected p-value
ϯ for a description of the statistical procedures used, please refer to the statistical a
ϯ ϯ only participants prescribed insulin used in analysesp = .040]. Body Mass Index (computed from medical chart
data) was significantly lower for those who engage in
SMBG at least once per week in a group of older women
[F(1, 33) =6.552, p = .016] but this difference was not ob-
served in other gender and age groups.
Perceived goal setting
Those who endorsed the statement “I have a target range
for my blood glucose” (58.6 %) had lower HbA1c [M = 7.96
(1.82)] levels than those who endorsed “no, I do not have a
target range” [M = 8.34 (2.04)] or “I don’t know” [M = 8.38
(2.09); F(2, 552) =4.024, p = 0.18]. Of those who indicated
that they had a target range for blood glucose, 43.15 % re-
ported that they were asked by their healthcare provider to
test their blood glucose levels at least once per week, com-
pared with 54.35 % of those who did not have a target and
46.9 % who were not sure. Of those same responders,
many in the “I have a target range” group left the item re-
lated to frequency of typical SMBG blank (60.17 %).
SMBG barriers and associations with glucose control
Specific barriers to SMBG related to cost, hating to stick
oneself, family support and negative mood were not found
to be associated with significant differences in metabolic
control (HbA1c %) while specific barriers related to sched-
uling concerns and feeling discouraged were (Table 1).
Specifically, being away from home several times per week
was associated with poorer metabolic control than being
away from home less frequently or at least once every day.
In those on insulin, significantly better control was found
in those never experiencing being “too busy” than in those
who were “too busy” several times per week. Similarly,
never “feeling discouraged” as a barrier to SMBG was as-
sociated with better metabolic control than experiencing





P value Holm- corrected significance
value comparison
, 9.63(0.44)
, 7.88(0.26) 173.50 0.003* 0.008
, 8.09(0.12) 851.00 0.004* 0.01
, 8.27(0.19) 239.50 0.005* 0.0125
, 7.42(0.50) 1854.00 0.007* 0.017
, 7.95(0.10)
, 9.47(0.52) 1854.00 0.003* 0.008
, 8.57(0.24) 5925.00 0.017 0.01
, 8.19(0.18)
, 9.63(0.41) 425.00 0.004* 0.008
, 9.16(0.46) 619.00 0.039 0.01
pproach section (above)
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This study contributes to the behavioral diabetes litera-
ture in providing a theoretically based, patient-centered
view of the SMBG experience in a clinical setting, which
has been lacking in previous research [4]. Prior research
points to the importance of considering patient perspec-
tives in diabetes self-management practices [8, 22]. How-
ever, previous empirical studies have largely failed to
examine patient perspectives of SMBG with patient sam-
ples from real-world clinical settings [23].
The findings of the present study reflect prevailing
uncertainty—that many patients are unclear about SMBG
recommendations, face practical barriers to testing and
are unsure of how to integrate SMBG into their lives. The
aim of the present study was to increase understanding of
patient perspectives of, practices of, and barriers to SMBG
within a self-regulation framework in a clinical setting.
Following is a discussion of the findings from within this
framework.Response rates
The finding that specific items related to SMBG recom-
mendations were left blank by a number of participants
(who did have a high rate of completion of items related
to other aspects of diabetes self-care) is likely reflective
of uncertainty about recommendations. Much can be
learned from considering patterns of (non)responding,
which may be viewed as analogous to considering rates
of drop out from behavioral interventions rather than
only focusing on those who successfully complete treat-
ment. This pattern bears a resemblance to the lack of a
consensus for specific SMBG recommendations for this
population in the medical field [7].SMBG practices and associations
Approximately half of participants reported engaging in
SMBG less than once or twice a week, if at all. Reported
SMBG frequency was variable and similar for all partici-
pants, regardless of insulin prescription status. Further,
more frequent engagement in SMBG was only associated
with better metabolic control in those not prescribed insu-
lin. There may be number of reasons for these findings.
For one, those prescribed insulin tended to have poorer
glucose control overall, leading to more varied HbA1c
levels throughout group, which may have manifested in
statistical concerns.
Though the perceived intended purpose of SMBG test-
ing was not examined explicitly, control was better in
those who indicated that they had a target for glucose
control; using SMBG to achieve glucose targets appears to
be critical to its effectiveness as a self-management tool.
The findings point to the importance of using SMBG as
part of a process of goal-directed, self-regulatory behavior.Demographic factors
Findings implicated gender and age as factors in the fre-
quency of encountering difficult barriers to SMBG; this
may reflect differences in perceptions and emotional re-
sponses to SMBG. For example, women reported a greater
frequency of encountering barriers despite no indication of
differences in SMBG frequency. Also, older adults reported
fewer barriers than young adults, suggesting that character-
istics common to older age, such a less chaotic lifestyle or
different health expectations, allows for easier integration
of SMBG into daily schedules. Due to study limitations,
the relationships between gender and age and SMBG bar-
riers cannot be adequately described. However, our results
suggest that individual differences, such as gender, should
be considered as a targeted outcome of interest for re-
search or a consideration in clinical intervention.
SMBG Barriers
Regardless of age, gender or insulin use status, SMBG
barriers related to scheduling were the most commonly
encountered and barriers related to cost and discomfort
were among the lowest. Being away from home had the
strongest relationship to metabolic control of the barriers
examined; participants who were away from home several
days in a week had poorer control than those away from
home less frequently and, interestingly, those who were
away from home every day had relatively good control.
For those prescribed insulin, having a busy schedule was
also related to poorer control, though this was not the
case for those not prescribed insulin. Additionally, reports
of practical and emotional barriers did not directly relate
to poorer control. These findings highlight the complex
experience of engaging in SMBG and barriers to SMBG.
Individual, patient factors may be extremely important in
the experience of SMBG.
To address barriers to SMBG, ideal treatment formats
may differ depending on individual factors. A one-on-one
treatment context can be useful for patients presenting
with many specific concerns. Alternatively, patients can be
organized into group interventions that can be tailored to
address similar needs [4]. When a patient is presenting
with difficulties that are mostly behavioral and related to
adherence, and are not reporting a significant amount of
emotional distress, a more behavioral approach can be
used. See a conceptual overview and detailed description
of a behavioral intervention for diabetes management in a
helpful review by Peyrot and Rubin [9].
Limitations
A significant challenge in the present study relates to the
use of a self-report SMBG measure developed for clinical
assessment. While useful for obtaining descriptive self-care
information to inform treatment decisions, many items re-
flect ranked response options, yielding ordinal data, which
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of statistical flexibility and power. It is recommended that
future studies consider the inclusion of additional continu-
ous variables that may allow for more detailed analyses re-
lated to SMBG testing and barrier frequency.
Conclusions
Despite the above limitations, the present findings con-
tribute to the literature by highlighting the patient ex-
perience of SMBG in individuals with Type 2 diabetes in
a clinical setting from a theoretical perspective. Specific-
ally, the findings point to frequent barriers experienced
by patients, and the prevalent uncertainty surrounding
recommendations. The finding that many patients face
uncertainty suggests a great need for future research ad-
dressing the translation of conceptually grounded, best
practice recommendations for SMBG into practice and
behavioral intervention in clinical settings. An interdiscip-
linary care team and integration of behavioral research can
contribute greatly to this endeavor by examining SMBG
in clinical settings in a systematic way and developing
evidence-based recommendations and strategies for ad-
dressing uncertainty and barriers to SMBG in these set-
tings. Recommendations and considerations for future
research and clinical translation are discussed in more
detail below.
Research recommendations
Research grounded in a conceptual model
Interdisciplinary diabetes care teams that include behav-
ioral scientists or mental health practitioners can contrib-
ute greatly to our understanding of the patient experience
of SMBG, and SMBG barriers, through expertise and ap-
plication of any number of supported health behavior the-
ories in existence. Application of these theories is needed
to inform understanding of the psychological, social and
behavioral processes that are involved in SMBG and can,
in turn, inform translational medicine. The present study
highlighted a complex relationship between individual
characteristics, health behaviors, the experience of barriers
and physiological outcomes. Conceptually grounded models
can help to explain the behavioral, social and cognitive
mechanisms that interplay and sustain these complex
relationships.
Clear, operational definitions of optimal SMBG
Inconsistency in research definitions of SMBG has led
to serious problems with inter-study comparison and
applicability to clinical practice. In addition to the need
to define SMBG frequency variables, the operational
definition of the utility of SMBG should be considered
(Is it being used to provide feedback to health care
team? Is it being used to make behavioral changes? Is it
lacking purpose?). This would allow for consideration ofthe underlying cognitive and coping process of SMBG
in addition to behavioral tracking.
Clinical research
Examination of the efficacy of clinical intervention for
diabetes-distress and adherence problems is needed. Spe-
cifically, it is as yet unknown whether some individuals
will benefit more from a solely behavioral or solely sup-
port intervention rather than an intervention that inte-
grates both foci [9].
Emphasize utility
While SMBG recommendations include timing and fre-
quency, it is also beneficial to emphasize the utility of
SMBG as a means of increasing personal involvement in
diabetes care. Utility is gaining attention in recommenda-
tions [24]; SMBG may be discussed as both a momentary
decision-making tool when away from the clinic working
toward a personal target and as helpful in informing
healthcare provider treatment choices in making clinical
adjustments [25]. Indeed, our findings indicate that having
a personal blood glucose target is associated with lower
HbA1c, relative to not having a target or being uncertain
of a personal target. However, there are very few research
studies that emphasize the use of SMBG for decision-
making, at present [26]. Further research should measure
this component in a systematic way.
Barriers to SMBG can often be managed through in-
formed clinical care and should be addressed before
implementing any long-term SMBG regimen. There is
burgeoning evidence that an integrated diabetes care
team is improved by addressing behavioral and psycho-
logical needs.
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